$NOVN Novan Announces Final Week-12 Visit for Last Patient in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum Contagiosum: — Topline data on track for readout before the end of Q2 2021 — Currently no FDA-approved therapies for the treatment of molluscum — Potential for NDA filing no later than Q3 2022 Source: novan.gcs-web.com/node/9161...
4
10
10 Likes